JPMORGAN CHASE & CO - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$5,875,516
+6.4%
363,809
+173.4%
0.00%0.0%
Q2 2023$5,522,033
-71.7%
133,061
-59.1%
0.00%
-50.0%
Q1 2023$19,540,952
+85613.4%
324,944
+4.5%
0.00%
-33.3%
Q4 2022$22,798
-99.9%
310,804
+44.3%
0.00%
+50.0%
Q3 2022$16,371,000
+6.5%
215,461
-2.6%
0.00%0.0%
Q2 2022$15,368,000
-41.3%
221,121
-30.0%
0.00%
-33.3%
Q1 2022$26,175,000
+44.5%
315,929
+30.9%
0.00%
+50.0%
Q4 2021$18,115,000
+285.8%
241,287
+496.9%
0.00%
+100.0%
Q3 2021$4,696,000
-32.8%
40,423
+28.3%
0.00%0.0%
Q2 2021$6,992,000
-67.4%
31,515
-80.6%
0.00%
-66.7%
Q1 2021$21,441,000
-32.8%
162,215
-12.1%
0.00%
-40.0%
Q4 2020$31,921,000
+97.7%
184,471
+24.6%
0.01%
+66.7%
Q3 2020$16,144,000
+139.5%
148,102
+30.3%
0.00%
+200.0%
Q2 2020$6,741,000
-29.7%
113,678
-20.2%
0.00%
-50.0%
Q1 2020$9,594,000
+39.6%
142,458
+74.7%
0.00%
+100.0%
Q4 2019$6,873,000
+73.6%
81,555
+54.1%
0.00%0.0%
Q3 2019$3,958,000
-47.1%
52,922
-57.0%
0.00%0.0%
Q2 2019$7,485,000
+111.1%
123,010
+67.1%
0.00%0.0%
Q1 2019$3,546,000
+128.5%
73,615
+58.7%
0.00%
Q4 2018$1,552,000
-10.2%
46,392
+40.7%
0.00%
Q3 2018$1,728,000
+153.0%
32,968
+51.1%
0.00%
Q2 2018$683,000
-55.0%
21,819
-68.7%
0.00%
Q1 2018$1,518,000
-37.5%
69,629
-42.1%
0.00%
-100.0%
Q4 2017$2,428,000
+1151.5%
120,174
+385.2%
0.00%
Q4 2016$194,000
+6366.7%
24,770
+16982.8%
0.00%
Q4 2015$3,0001450.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders